BiotechTube
Home/Worldwide Clinical Trials/Sherilyn Adcock, RPh, PhD
SA

Sherilyn Adcock, RPh, PhD

Chief Scientific Officer, Early Phase Development

Worldwide Clinical Trials

Therapeutic Areas

Rare DiseaseCardiovascular & MetabolicCell & Gene TherapyOncologyNeuroscienceImmune-Mediated Inflammatory Diseases

Leadership Team at Worldwide Clinical Trials

AM
Alistair Macdonald
Chief Executive Officer
MM
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
View full Worldwide Clinical Trials profile